Skip to content

INTIBIO: what changed

BE 0737.613.932NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparationsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€91,024
2024 · €49,386+€41,638
Equity
€145,987
2024 · €54,963+€91,024
Cash
€29,557
2024 · €19,367+€10,190
Balance sheet total
€407,778
2024 · €371,609+€36,168

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€32,554

    down €32,554 (-33.9%), from €95,932 to €63,378

    of which Trade receivables: -€29,857

  • Tangible fixed assets +€24,220

    up €24,220 (+111%), from €21,786 to €46,006

    of which Furniture and vehicles: +€26,796

  • Intangible fixed assets +€17,235

    up €17,235 (+74.1%), from €23,260 to €40,494

  • Cash +€10,190

    up €10,190 (+52.6%), from €19,367 to €29,557

    mainly Net result for the year (+€91,024) and Debts after one year (+€66,043)

  • Deferred charges and accrued income +€8,749

    up €8,749 (+264%), from €3,313 to €12,062

Equity and liabilities
  • Reserves +€91,024

    up €91,024 (+175%), from €51,963 to €142,987

  • Other debts -€83,148

    down €83,148 (-54.1%), from €153,656 to €70,508

  • Debts after one year +€66,043

    up €66,043 (+217%), from €30,378 to €96,421

  • Trade debts -€37,578

    down €37,578 (-43.6%), from €86,231 to €48,652

  • Current portion of long-term debt +€21,446

    up €21,446 (+223%), from €9,625 to €31,070

Income statement
  • Gross operating margin +€142,415

    up €142,415 (+105%), from €135,600 to €278,015

  • Staff costs +€73,271

    up €73,271 (+130%), from €56,352 to €129,623

  • Depreciation +€14,451

    up €14,451 (+249%), from €5,798 to €20,249

  • Taxes +€12,676

    up €12,676 (+70.3%), from €18,029 to €30,706

  • Financial charges +€2,898

    up €2,898 (+97.0%), from €2,987 to €5,885

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €49,386
Gross operating margin +€142,415
Staff costs -€73,271
Depreciation -€14,451
Write-downs +€2,294
Other operating charges +€216
Financial income +€8
Financial charges -€2,898
Taxes -€12,676
Result 2025 €91,024
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€15,595
Investment -€61,704
Financing +€87,489
Cash 2024 €19,367
Net result for the year +€91,024
Depreciation +€20,249
Stocks and contracts -€8,329
Receivables within one year +€32,554
Deferred charges and accrued income -€8,749
Trade debts -€37,578
Tax, wage and social debts -€15,750
Other debts -€83,148
Accrued charges and deferred income -€5,869
Investment in fixed assets (net) -€61,704
Debts after one year +€66,043
Current portion of long-term debt +€21,446
Cash 2025 €29,557
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €371,609 €407,778 +€36,168 +9.7%
Fixed assets 21/28 €45,045 €86,500 +€41,455 +92.0%
Intangible fixed assets 21 €23,260 €40,494 +€17,235 +74.1%
Tangible fixed assets 22/27 €21,786 €46,006 +€24,220 +111%
Plant, machinery and equipment 23 €21,786 €19,210 -€2,576 -11.8%
Furniture and vehicles 24 - €26,796 +€26,796
Current assets 29/58 €326,564 €321,278 -€5,287 -1.6%
Stocks and contracts in progress 3 €207,951 €216,280 +€8,329 +4.0%
Stocks 30/36 €207,951 €216,280 +€8,329 +4.0%
Amounts receivable within one year 40/41 €95,932 €63,378 -€32,554 -33.9%
Trade receivables 40 €78,883 €49,026 -€29,857 -37.8%
Other amounts receivable 41 €17,050 €14,352 -€2,698 -15.8%
Cash at bank and in hand 54/58 €19,367 €29,557 +€10,190 +52.6%
Deferred charges and accrued income 490/1 €3,313 €12,062 +€8,749 +264%
Total equity and liabilities 10/49 €371,609 €407,778 +€36,168 +9.7%
Equity 10/15 €54,963 €145,987 +€91,024 +166%
Contributions 10/11 €3,000 €3,000 = 0.0%
Reserves 13 €51,963 €142,987 +€91,024 +175%
Distributable reserves 133 €51,963 €142,987 +€91,024 +175%
Profit (loss) carried forward 14 €0 - =
Amounts payable 17/49 €316,646 €261,790 -€54,856 -17.3%
Amounts payable after more than one year 17 €30,378 €96,421 +€66,043 +217%
Financial debts 170/4 €30,378 €96,421 +€66,043 +217%
Amounts payable within one year 42/48 €278,399 €163,369 -€115,030 -41.3%
Current portion of amounts payable after more than one year 42 €9,625 €31,070 +€21,446 +223%
Trade debts 44 €86,231 €48,652 -€37,578 -43.6%
Suppliers 440/4 €86,231 €48,652 -€37,578 -43.6%
Taxes, remuneration and social security 45 €28,888 €13,139 -€15,750 -54.5%
Taxes 450/3 €21,962 €468 -€21,494 -97.9%
Remuneration and social security 454/9 €6,926 €12,671 +€5,745 +82.9%
Other amounts payable 47/48 €153,656 €70,508 -€83,148 -54.1%
Accrued charges and deferred income 492/3 €7,869 €2,000 -€5,869 -74.6%
Remuneration, social security and pensions 62 €56,352 €129,623 +€73,271 +130%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €5,798 €20,249 +€14,451 +249%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €2,294 €0 -€2,294 -100%
Other operating charges 640/8 €753 €537 -€216 -28.7%
Gross operating margin 9900 €135,600 €278,015 +€142,415 +105%
Operating profit (loss) 9901 €70,403 €127,607 +€57,204 +81.3%
Financial income 75/76B - €8 +€8
Recurring financial income 75 - €8 +€8
Financial charges 65/66B €2,987 €5,885 +€2,898 +97.0%
Recurring financial charges 65 €2,987 €5,885 +€2,898 +97.0%
Profit (loss) for the period before taxes 9903 €67,416 €121,730 +€54,314 +80.6%
Income taxes 67/77 €18,029 €30,706 +€12,676 +70.3%
Profit (loss) for the period 9904 €49,386 €91,024 +€41,638 +84.3%
Profit (loss) for the period to be appropriated 9905 €49,386 €91,024 +€41,638 +84.3%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€232,007 to €303,712

Midpoint €261,884 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €105,493
Capitalised earnings €358,521 to €501,930
Indication €232,007 to €303,712

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€145,987
Intangible fixed assets (21)
-€40,494
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€105,493

Capitalised earnings

net result for the year (9904)
2025
€91,024
2024
€49,386
2023
€10,170
2022
€29,112
2021
€23,830
Average result
€50,193
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€358,521 / €418,275 / €501,930

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.